.Ideaya Biosciences is wagering $400 million in biobucks that a bispecific antibody-drug conjugate (...
.Our team presently recognize that Takeda is planning to locate a pathway to the FDA for epilepsy me...
.Immunology biotech VBI Injections is actually diverting precariously near the point of no return, w...
.It's difficult to muscle in on a space as competitive as immunology, but Celldex Therapies believes...
.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Rehabs as well as a preclinical immun...
.Ventyx Biosciences' Crohn's health condition medication carried out not aid people obtain remission...
.Cognition Rehabs' stage 2 SHINE test has taken a number of the luster off the Alzheimer's condition...
.Bristol Myers Squibb has had a whiplash change of mind on its BCMA bispecific T-cell engager, halti...
.Charles Baum, M.D., Ph.D., that supervised Mirati Therapeutics' $ 5.8 billion purchase to Bristol M...
.After connecting to greater than 200 providers to companion a Tourette disorder treatment that reve...